Additional file 1 of An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma– results from a nation-wide study covering 50 years in Iceland ...

• Main Authors: Runarsson, Thorri Geir, Bergmann, Andreas, Erlingsdottir, Gigja, Petursdottir, Vigdis, Heitmann, Leon Arnar, Johannesson, Aevar, Asbjornsson, Viktor, Axelsson, Tomas, Hilmarsson, Rafn, Gudbjartsson, Tomas
• Format: Text
• Language: unknown
• Published: figshare 2024
• Subjects: Medicine; Cell Biology; Biotechnology; Biological Sciences not elsewhere classified; Mathematical Sciences not elsewhere classified; Developmental Biology; Cancer; Science Policy; TNM; Iceland
• Online Access: https://dx.doi.org/10.6084/m9.figshare.25815110; https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_An_epidemiological_and_clinicopathological_study_of_type_1_vs_type_2_morphological_subtypes_of_papillary_renal_cell_carcinoma_results_from_a_nation-wide_study_covering_50_years_in_Iceland/25815110

Supplementary Material 1: Figure S1. Estimated CSS for pRCC patients diagnosed 1971-2020 with pRCC on different TNM stages. Figure S1 shows estimated CSS depending on TNM stage for pRCC-1 and 2 taken together. One-year CSS for TNM stage I-IV was 98.7% (95% CI: 0.98, 1), 95.1% (95% CI: 0.92, 0.99), 88.8% (95% CI: 0.86, 0.92) and 42.9% (95% CI: 0.37, 0.49), respectively, and 5-year CSS was 96.5% (95% CI: 0.95, 98), 82.8% (95% CI: 0.77, 0.89), 72.4% (95% CI: 0.68, 0.78) and 14.4% (95% CI: 0.11, 0.19) for the same stages. Five-year OS was 85% (95% CI: 0.82, 0.88), 72.6% (95% CI: 0.66, 0.80), 62.5% (95% CI: 0.58, 0.68) and 12.6% (95% CI: 0.09, 0.17), for TNM stages I-IV, respectively. ...